EZH2 and lymphoma: The frequent tyrosine 641 (Y641) mutation of EZH2 in lymphomas is a gain-of-function mutation that enhances tri-methylation of H3K27 in concert with EZH2WT that performs the H3K27 mono-methylation, eventually shutting down key B-cell genes [157,158].